Clinical Trial Update: Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial (EXTINGUISH ARDS) evaluating extracellular vesicle treatment for acute respiratory distress syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Extracellular Vesicle Treatment

Snippet

Sponsor: Direct Biologics, LLC | Conditions: Acute Respiratory Distress Syndrome, ARDS | Phase 3 | Status: RECRUITING